A widespread recall of medical cannabis vaping products in the US state of Pennsylvania has given rise to questions about the role flavour additives play in product safety and has left patients with more questions than answers.
The Pennsylvania Department of Health (DOH) Office for Medical Marijuana issued the recall in February, questioning the safety of 670 products. A local newspaper estimated the recall to affect $12m worth of products, though the paper did not explain how it reached that figure.